Amiodarone has become an important drug for the treatment of supraventricul
ar and ventricular arrhythmias, in short-term inpatient and outpatient sett
ings. It may also have a role in affecting outcome in patients at high risk
for arrhythmic events and sudden death; its place among available therapie
s is being established in clinical trials.